Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Disease
- Therapeutic
- Proteins
- Diagnostic
- Cancer
- Catheter
- Coating
- Device
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 240588
Licensor grants a sole and exclusive royalty bearing right and license for the Licensed Territory under Patent Rights and Invention to make, have made, use and sell or have sold on its behalf Product or Licensed Process, including the right to sublicense third parties.
Invention shall mean individually and collectively Research Invention and Background Invention. Research Inventions are from the sponsored research. The Background Inventions are from prior to the effective date.
Nitric oxide is a naturally-occurring compound that is synthesized in cells to regulate a broad range of cellular reactions. Many disease states are associated with a deficiency in nitric oxide and might benefit from nitric oxide-enhancing medicines. For example, depleted levels of nitric oxide have been implicated in diseases such as heart failure, pulmonary hypertension and sexual dysfunction. Additionally, nitric oxide-enhancing medicines have been shown to minimize side effects associated with a variety of medications, including a broad range of anti-inflammatory medications.
IPSCIO Record ID: 248096
In the original agreement, Licensor grants a sole and exclusive royalty bearing right and license for the Licensed Territory under Patent Rights and Invention to make, have made, use and sell or have sold on its behalf Product or Licensed Process, including the right to sublicense third parties.
Nitrosylation of Protein SH Groups And Amino Acid Residues As A Therapeutic Modality, and,
S-Nitroso-N- Acetylcysteine As A Treatment For Airway Obstruction, and other related patent applications.
Invention shall mean individually and collectively Research Invention and Background Invention. Research Inventions are from the sponsored research. The Background Inventions are from prior to the effective date.
Nitric oxide (nitrogen oxide[3] or nitrogen monoxide) is a colorless gas with the formula NO. It is one of the principal oxides of nitrogen. Nitric oxide is a free radical, i.e., it has an unpaired electron, which is sometimes denoted by a dot in its chemical formula, i.e., ·NO. Nitric oxide is also a heteronuclear diatomic molecule, a historic class that drew researches which spawned early modern theories of chemical bonding.
IPSCIO Record ID: 240586
The term Process shall mean any or method for the production, manufacture or use of any Product.
– Cardiovascular, gastrointestinal, and pulmonary research, and research relating to erectile
dysfunction and ureteral relaxation, utilizing nitric oxide compounds, nitrosothiols, nitrosoproteins, other nitrosylated compounds and/or agonists and antagonists thereof, and other compounds which mediate nitric oxide, and,
– Research relating to erectile dysfunction and ureteral relaxation, utilizing nitric oxide compounds, nitrosothiols, nitrosoproteins, other nitrosylated compounds and/or agonists and antagonists thereof, and other compounds which mediate nitric oxide.
IPSCIO Record ID: 243410
For the Commercialization Licenses, Licensor grants to Licensee
– an exclusive right and license in the Territory, with the right to grant sublicenses, under Licensors rights in Licensor Intellectual Property and Joint Intellectual Property, to make, use, sell, offer to sell and import Royalty-Bearing Products incorporating Licensor Delivered Compounds; and
– a non-exclusive right and license in the Territory, with the right to grant sublicenses, under Licensors rights in the Licensors Intellectual Property other than the Licensor Composition Patent Rights, to make, use, sell, offer to sell and import Royalty-Bearing Products incorporating Limited License Compounds.
Product shall mean a medical device or a specialty catheter product developed for use in the Field, in either case incorporating one or more Licensor Nitric Oxide Releasing Compounds. Nitric Oxide Releasing Compounds shall mean compounds that donate, release and/or directly or indirectly transfer nitrogen monoxide, such that the biological activity of the nitrogen monoxide is expressed at an intended site of action.
Product relates to stents coated with nitric oxide-releasing compounds.
This development and license agreement is for the research, development and commercialization of cardiovascular stents coated with nitric oxide-enhancing medicines. Stents, or wire mesh devices, are typically inserted into narrowed coronary arteries to maintain blood flow.
